Yayın:
Reduction of methotrexate nerphrotoxicity with verapamil in rats

dc.contributor.authorErol, Kevser
dc.contributor.authorGürer, Fi̇rdevs
dc.contributor.authorCingi, M.I.
dc.contributor.authorBayçu, Cengiz
dc.contributor.authorErol, Adnan
dc.contributor.orcid0000-0002-8808-6616
dc.contributor.orcid0000-0001-7339-9348
dc.contributor.orcid0000-0002-2741-9755
dc.date.accessioned2025-11-13T20:53:02Z
dc.date.issued1990-07-01
dc.identifier.doihttps://doi.org/10.1016/0014-2999(90)92011-7
dc.identifier.endpage1710
dc.identifier.issn0014-2999
dc.identifier.issue5
dc.identifier.openalexW2066175281
dc.identifier.startpage1710
dc.identifier.urihttps://hdl.handle.net/11421/12875
dc.identifier.urihttps://doi.org/10.1016/0014-2999(90)92011-7
dc.identifier.volume183
dc.language.isoen
dc.relation.ispartofEuropean Journal of Pharmacology
dc.rightsrestrictedAccess
dc.subjectVerapamil
dc.subjectPharmacology
dc.subjectMethotrexate
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectCalcium
dc.subject.sdg2
dc.titleReduction of methotrexate nerphrotoxicity with verapamil in rats
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5047198917
local.authorid.openalexA5021873343
local.authorid.openalexA5024664648
local.authorid.openalexA5075694960
local.authorid.openalexA5083143131

Dosyalar

Koleksiyonlar